Exponent (EXPO) Set to Announce Earnings on Thursday

Exponent (NASDAQ:EXPO) is scheduled to be announcing its earnings results after the market closes on Thursday, April 25th. Analysts expect the company to announce earnings of $0.46 per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Exponent (NASDAQ:EXPO) last posted its earnings results on Thursday, February 1st. The business services provider reported $0.41 earnings per share for the quarter, missing the consensus estimate of $0.44 by ($0.03). Exponent had a return on equity of 28.49% and a net margin of 18.69%. The company had revenue of $113.87 million during the quarter, compared to analyst estimates of $119.11 million. During the same quarter last year, the firm posted $0.44 earnings per share. The firm’s revenue for the quarter was up 1.1% compared to the same quarter last year. On average, analysts expect Exponent to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Exponent Stock Down 0.5 %

NASDAQ:EXPO opened at $77.73 on Thursday. The company’s 50 day moving average is $79.31 and its 200-day moving average is $82.15. Exponent has a 12 month low of $64.61 and a 12 month high of $101.65. The firm has a market cap of $3.93 billion, a price-to-earnings ratio of 39.86 and a beta of 0.68.

Exponent Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 22nd. Investors of record on Friday, March 8th were paid a $0.28 dividend. The ex-dividend date of this dividend was Thursday, March 7th. This is a positive change from Exponent’s previous quarterly dividend of $0.26. This represents a $1.12 dividend on an annualized basis and a yield of 1.44%. Exponent’s dividend payout ratio (DPR) is presently 57.44%.

Insider Activity at Exponent

In other Exponent news, insider Eric Guyer sold 3,367 shares of the firm’s stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $78.49, for a total value of $264,275.83. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 2.20% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Norges Bank bought a new stake in shares of Exponent in the 4th quarter valued at approximately $51,619,000. Morgan Stanley raised its stake in Exponent by 87.7% during the fourth quarter. Morgan Stanley now owns 1,057,052 shares of the business services provider’s stock worth $104,743,000 after acquiring an additional 493,847 shares in the last quarter. Ameriprise Financial Inc. lifted its holdings in shares of Exponent by 77.7% during the first quarter. Ameriprise Financial Inc. now owns 565,156 shares of the business services provider’s stock valued at $56,340,000 after acquiring an additional 247,075 shares during the period. Citadel Advisors LLC boosted its stake in shares of Exponent by 550.2% in the 2nd quarter. Citadel Advisors LLC now owns 172,567 shares of the business services provider’s stock valued at $15,785,000 after purchasing an additional 146,028 shares in the last quarter. Finally, Fred Alger Management LLC acquired a new stake in shares of Exponent in the 1st quarter valued at $11,541,000. Institutional investors and hedge funds own 92.37% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on EXPO. Truist Financial decreased their price target on shares of Exponent from $110.00 to $95.00 and set a “buy” rating for the company in a report on Friday, February 2nd. StockNews.com raised Exponent from a “sell” rating to a “hold” rating in a report on Monday, March 4th.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.